Effect of SGLT2 inhibitors on the course of chronic heart failure in patients with type 2 diabetes mellitus

Effect of SGLT2 inhibitors on the course of chronic heart failure in patients with type 2 diabetes mellitus

Diabetes mellitus (DM) is a group of metabolic diseases characterized by chronic hyperglycemia, which is the result of impaired insulin secretion, insulin action, or both. Chronic hyperglycemia in diabetes is accompanied by damage, dysfunction, and failure of various organs, especially the eyes, kid...

Full description

Bibliographic Details
Main Authors: A. N. Payudis, O. A. Efremova, L.  A. Kamyshnikova, Iu. S. Pavlova, O. V. Dudchenko, I. I. Khamnagadaev, T.  P. Golivets
Format: Article
Language:Russian
Published: ABV-press 2022-10-01
Series:Klinicist
Subjects:
type 2 diabetes
chronic heart failure
sglt2 inhibitors
canagliflozin
dapagliflozin
empagliflozin
cardioprotection
nephroprotection
ketoacidosis
natriuresis
side effects of sglt2 inhibitors
Online Access:https://klinitsist.abvpress.ru/Klin/article/view/493

Internet

https://klinitsist.abvpress.ru/Klin/article/view/493

Similar Items